Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Earnings release
confidence 98%
filed 2026-06-25
Item 2.02
This is a clear earnings release disclosing Capstone Energy+'s financial results for fiscal year 2026 ended March 31, 2026. The filing explicitly states "On June 25, 2026, Capstone Energy+, Inc. (the "Company") issued a press release announcing its financial results for the fiscal year and fourth quarter ended March 31, 2026." The press release reports revenue growth of 24% to $106.0 million, gross profit increase of 45% to $33.9 million, and a return to full-year profitability with net income of $2.8 million. This is material to investors as it demonstrates significant operational improvement and profitability achievement.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-25
Item 5.02
Michael Angelina, a director of RLI Corp, notified the Company on June 22, 2026 of his resignation from the Board effective June 30, 2026. The disclosure explicitly states his departure and the reason (intention to join another insurance company's board), with no disagreement cited. This is a clear director departure under Item 5.02(b), material to investors as board composition affects governance and oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-25
Item 5.07
This Item 5.07 disclosure reports the results of Protalix's 2026 Annual Meeting of Stockholders held on June 25, 2026, including voting outcomes on four proposals: election of eight directors, advisory approval of named executive officer compensation, approval of an amended stock incentive plan increasing available shares by 3.5 million, and ratification of the independent auditor (Kesselman & Kesselman/PwC). The detailed vote tallies for each proposal are provided, which is the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 95%
filed 2026-06-25
The NYSE notified the Company on June 24, 2026 of its determination to commence delisting proceedings for the Company's warrants (LANV-WT) due to "abnormally low selling price" pursuant to NYSE Listed Company Manual Section 802.01D. Trading in the warrants has been suspended immediately, and the NYSE will apply to the SEC to delist the warrants. This is a direct notice of delisting action, matching the delisting_risk category.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-06-25
Item 2.03
CNH Industrial Capital LLC completed a $600 million offering of 4.950% notes due 2031 on June 25, 2026, pursuant to an underwriting agreement and registration statement. This material debt issuance was disclosed under Items 2.03 and 8.01, with supporting debt instruments and agreements incorporated as exhibits.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-25
Item 5.07
This Item 5.07 disclosure reports the final voting results from Gain Therapeutics' June 24, 2026 annual meeting of stockholders, including the election of seven directors and ratification of Ernst & Young AG as independent auditor. The detailed vote tallies for each nominee and the auditor ratification proposal are the core content, matching the shareholder_vote_results event type precisely.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-06-25
Item 8.01
Forge Nano announced a strategic partnership with Samsung SDI to construct a 3 GWh/year battery manufacturing facility in North Carolina, with Samsung SDI providing operational support, a conditional procurement agreement, and distribution rights. This is a material operational and strategic business event—a major partnership and capital commitment ($300–330M, subsidized by $100M DOE grant) that would affect investor assessment of Forge Nano's growth prospects and competitive positioning. While the filing occurs during a pending SPAC merger, the partnership itself is a discrete operational milestone that does not fit the specific categories of M&A activity, debt issuance, or other named financial events.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-25
Item 5.02
Archrock appointed Mohit Singh as Senior Vice President and Chief Financial Officer, effective July 6, 2026. Singh brings 25+ years of energy industry experience, including prior roles as CFO of Chesapeake Energy and senior leadership at BP and Goldman Sachs. The appointment includes substantial compensatory arrangements ($650,000 base salary, $2.3M annual equity target, $1.5M sign-on award).
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-06-25
Item 8.01
The Company announced the pricing of a $500 million private offering of 5.875% unsecured senior notes due 2029, with settlement expected on July 10, 2026. This is a material creation of a new direct financial obligation. The disclosure explicitly states the principal amount, coupon rate, maturity date, and pricing terms, and indicates the proceeds will be used to refinance existing debt or fund green/social projects, which is a core debt issuance event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-25
Item 5.07
This Item 5.07 disclosure reports the results of Journey Medical's 2026 Annual Meeting held on June 24, 2026, including voting outcomes for two proposals: (i) election of six directors and (ii) ratification of KPMG LLP as independent auditor. The filing provides detailed vote tallies for each director and the auditor ratification, which is the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-06-25
EX-99.1
ProQR announced the pricing of an underwritten registered direct offering of 27.6 million ordinary shares at $1.81 per share for ~$50 million gross proceeds, plus a concurrent private placement of 5.1 million shares to Eli Lilly for ~$9.2 million. This is a material equity issuance that dilutes existing shareholders and raises capital through unregistered (private placement) and registered direct offerings, fitting the dilutive_issuance category. The concurrent private placement to Lilly is explicitly noted as exempt from registration under Section 4(a)(2) of the Securities Act.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-25
Item 5.07
This is a clear disclosure of shareholder voting results from a special meeting held on June 25, 2026. The filing reports the vote tallies for two proposals: (1) approval of a reverse stock split amendment with a ratio range of 1-for-5 to 1-for-25, which passed with 26,898,163 votes for versus 751,966 against, and (2) approval of an adjournment proposal, which also passed. A reverse stock split is a material capital structure event that affects all shareholders, making the voting results material to investors.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-06-25
Item 8.01
The Board of Directors authorized a share repurchase program of $800 million through December 31, 2029. Share repurchases are a form of capital return to shareholders and fall within the dividend_distribution category, which encompasses "share-repurchase programs" alongside dividends and distributions. The $800 million authorization is material to a reasonable investor as it signals capital allocation strategy and shareholder value commitment.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-25
Item 5.02
The filing discloses two executive appointments: Gregory S. Patton was appointed Chief Executive Officer and Board member (promoted from CFO), and Michael Shelly was appointed Executive Vice President and Chief Financial Officer. While the disclosure also includes compensatory arrangements (employment agreements, equity awards, and PSU amendments), the principal disclosed action centers on these two appointments to key leadership roles. The appointment of a new CEO is a material governance event affecting the registrant's leadership structure.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-06-25
Item 1.01
SUI Group Holdings entered into an Amended and Restated Digital Asset Loan Agreement on June 19, 2026, whereby it will loan an additional 4,000,000 SUI tokens to BlueFin (totaling 6,000,000 SUI tokens), with BlueFin paying an 11% revenue share fee through September 2028. This material capital deployment and financial obligation creates a direct financial relationship with defined terms and recurring revenue participation.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 98%
filed 2026-06-25
Item 2.03
Southern Copper Corporation completed a registered public offering of $1.25 billion in 5.350% unsecured notes due 2036, with net proceeds of approximately $1.24 billion. The proceeds will be used for the Tia Maria project development, capital expenditures, and general corporate purposes.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-06-25
Item 5.02
The Compensation Committee approved material changes to CFO John North's compensation package, including: (i) a base salary increase from $175,000 to $275,000 effective October 1, 2026; (ii) confirmation of a 100% annual target bonus opportunity; and (iii) modification of a market condition performance-vesting RSU arrangement with potential grants totaling up to $19.1 million ($1.6M + $7M + $10.5M) upon achievement of specified market capitalization, stock price, or EBITDA thresholds, plus additional change-of-control provisions. This is a classic executive compensation disclosure under Item 5.02(e).
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-06-25
Item 1.01
ON Semiconductor entered into a definitive Agreement and Plan of Reorganization to acquire Synaptics Incorporated in an all-stock transaction valued at approximately $7 billion, with an exchange ratio of 1.350 onsemi shares per Synaptics share, with expected closing in mid-2027.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-25
Item 3.02
BlackRock Private Credit Fund completed an unregistered private placement of 183,697.592 Institutional Class Shares for $4,345,329.81 to feeder vehicles, exempt under Section 4(a)(2) and Regulation S. This represents a significant capital raise and dilution to existing shareholders.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-06-25
Item 8.01
BlackRock Private Credit Fund declared regular distributions to shareholders across three share classes (Institutional, Class S, and Class D) with a gross per-share amount of $0.1784 (varying net amounts by class), record date of June 29, 2026, and payment date of July 29, 2026.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-06-25
Item 1.01
Synaptics entered into a definitive Agreement and Plan of Reorganization with ON Semiconductor Corporation for an all-stock merger transaction valued at approximately $7 billion, with a fixed exchange ratio of 1.350 shares of onsemi common stock per Synaptics share. Synaptics will survive as an indirect wholly-owned subsidiary of onsemi, subject to stockholder approval and regulatory clearance, with expected closing in mid-2027.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-25
Item 2.02
This is a clear earnings release for Acuity Inc.'s fiscal 2026 third-quarter results (quarter ended May 31, 2026), issued on June 25, 2026. The press release discloses net sales of $1.2B (up 2% YoY), operating profit of $193M (up 38% YoY), and diluted EPS of $4.56 (up 46% YoY), along with detailed segment performance and cash flow metrics. The filing explicitly states the press release is attached as Exhibit 99.1 and incorporated by reference under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings disclosures.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-25
Item 5.02
Jonathan J. Mazelsky was appointed as a Class II director of Insulet Corporation, effective July 1, 2026. Mazelsky brings significant executive experience, including 14 years at IDEXX Laboratories where he served as President and CEO, and prior leadership roles at Philips and Agilent.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-06-25
Item 8.01
Constellation announced an extension of exchange offers for approximately $2.3 billion in unregistered notes originally issued in January 2026, now being exchanged for registered notes with identical terms. While technically an exchange rather than a new issuance, this disclosure involves the creation and management of a material direct financial obligation ($2.3 billion in aggregate principal). The event is material to investors as it affects the company's capital structure and debt obligations, though the core financial obligation itself was created in January 2026; this filing documents the extension of the registration/exchange process for those obligations.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-06-25
EX-99.1
This press release discloses results of a comprehensive geophysical survey program at the Corani Silver Project, including airborne magnetic surveys and induced polarization-resistivity surveys totaling over 90 km and 600 km respectively. The disclosure identifies multiple high-priority exploration targets (Corani West, Corani East Extension, Corani South) with geophysical signatures consistent with the Corani deposit, and announces the commencement of a first exploration drilling program in over a decade with four drill rigs active and first assays expected in July. This is a material operational/exploration milestone for a mining company, affecting investor assessment of the project's scale and development trajectory, but does not fit the discrete event categories (M&A, earnings, executive changes, etc.) and is therefore best classified as an operational event.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-06-25
EX-99.1
This press release discloses multiple operational and strategic milestones for a uranium-vanadium development company: completion of Phase One construction at Velvet-Wood with production targeted for end-2026, installation of monitoring wells at Shootaring Canyon Mill, acquisition of BRS Engineering, equipment procurement, and an updated PEA showing strong economics (106% pre-tax IRR, US$606M NPV, 1.3-year payback). While the PEA itself is a technical/economic assessment rather than a discrete earnings event, the bundle of operational achievements, construction completion, and strategic acquisitions constitutes material operational progress toward production. The disclosure does not fit neatly into a single named category (not a results release, M&A completion, or workforce action), making `operational_other` the most appropriate classification for this multi-faceted operational and strategic update.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-06-25
EX-99.1
This press release announces Intermap's award of a third DOD research subcontract for GPS-denied navigation technology development. The disclosure describes a material operational and strategic milestone—a significant government contract win that expands the company's defense and aerospace portfolio and validates its geospatial intelligence capabilities. While not a discrete M&A transaction, earnings event, or executive change, it represents a material operational achievement that would affect a reasonable investor's assessment of the company's growth trajectory and market positioning in the defense sector.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-06-25
EX-99.1
This press release discloses the results of Cellectis' shareholders general meeting held on June 25, 2026, reporting that resolutions 1–29 were adopted and resolution 30 was rejected, with approximately 55.84% of voting rights exercised. This is a direct disclosure of shareholder vote results, matching Item 5.07 of the 8-K taxonomy and the `shareholder_vote_results` event type. The outcome of shareholder votes on board-recommended resolutions is material to investors assessing governance and strategic direction.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-06-25
Item 8.01
The Board of Directors declared a cash dividend of $0.32 per share payable on September 3, 2026, to stockholders of record as of August 20, 2026. This is a routine quarterly dividend distribution, which is a material event affecting shareholders' returns and the company's capital allocation policy.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-06-25
EX-99.1
This press release announces Titan Mining's receipt of Conditional Selection Notices from the U.S. Army for Enhanced Use Lease opportunities to establish graphite purification facilities at two strategic defense installations (Pine Bluff Arsenal and Anniston Army Depot). The disclosure describes a landmark public-private partnership for critical minerals processing infrastructure, with a 50-year lease term, zero taxpayer cost, and construction targeted for H2 2027. While this is a significant strategic and operational milestone for the company's graphite business and domestic supply chain positioning, it does not fit the specific event categories of M&A activity (no acquisition/merger), debt issuance, or other named financial/governance events. It is clearly material to investors as it represents a major operational and strategic development affecting the company's growth trajectory and market positioning in critical minerals.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-06-25
EX-99.1
Equinox Gold announces execution of 20-year land access agreements with three communities hosting its Los Filos Mine in Mexico and initiation of planning for mine restart and expansion. This is a material operational and strategic milestone—securing long-term community agreements is a prerequisite for mine restart and production expansion at a world-class deposit containing 5.4 million ounces of proven and probable reserves. The announcement discloses commencement of heap leach restart activities and technical studies to evaluate CIL facility construction and production expansion, which are significant operational developments affecting the company's future production profile and value creation.
View raw filing on EDGAR →
8-K
Covenant Breach
confidence 90%
filed 2026-06-25
Item 1.01
Americas CarMart has experienced or anticipates experiencing events of default under its Credit Agreement, including failure or expected failure to comply with financial covenants (minimum liquidity, Collateral Coverage Ratio) and reporting obligations. The company entered into a First Amendment and Limited Waiver with lenders, paying $18 million in fees to secure a waiver of these defaults for a specified period, though uncertainty remains about achieving a sustainable capital structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-06-25
Item 5.02
The company appointed Gilbert E. Nathan and Michael J. Wartell as independent directors and appointed Marie Persichetti as Chief Financial Officer effective August 1, 2026, replacing Jonathan Collins who resigned effective July 31, 2026. These appointments were made in accordance with the company's obligations under the Credit Agreement amendment and include detailed compensation and retention arrangements.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 92%
filed 2026-06-25
Enlight announces the financial close of a debt financing framework agreement for its CO Bar complex, securing construction financing commitments totaling $2,622 million from seven major financial institutions (Wells Fargo, BNP Paribas, Crédit Agricole, Natixis, Norddeutsche Landesbank, Societe Generale, and MUFG Bank). The disclosure details the debt structure, including conversion to term loans with 25-year amortization for solar and 20-year for storage, all-in interest rate of 5.9%, and parent guarantor obligations—all hallmarks of a material debt issuance event.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 85%
filed 2026-06-25
The 6-K discloses results of Silicom's Annual General Meeting of Shareholders held June 3, 2026, including approval of director re-election, executive salary increases, auditor appointment, and notably the rejection and subsequent override of RSU grants to the CEO and Chairman. The override of shareholder rejection of executive compensation and the conditional approval of RSUs tied to a $83 million revenue threshold are material governance and compensation events affecting investor assessment of executive incentives and board authority.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 95%
filed 2026-06-25
EX-99.1
The exhibit discloses an update on withholding tax procedures in connection with a dividend distribution of $0.50 per ordinary share (approximately $10 million) expected to be paid on July 8, 2026, as previously announced on May 26, 2026. The document details the Israeli Tax Authority ruling on withholding tax rates and procedures for shareholders receiving this dividend, making it a material disclosure of a dividend distribution event.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-06-25
Item 5.02
The filing discloses the departure of Asaf Alperovitz as Chief Financial Officer, effective May 31, 2026, following his notification in March 2026. While the section also mentions a special cash bonus approved by the Compensation Committee, the principal disclosed action is the CFO's departure. The bonus is secondary and appears to be a severance/transition arrangement rather than a prospective compensation arrangement, making exec_departure the most salient classification.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-06-25
EX-99.1
This exhibit is a press release announcing expanded preclinical study results for PRF-110, the company's lead product candidate, showing comparable analgesic efficacy to an approved benchmark (ZYNRELEF) with favorable pharmacokinetic properties. While the disclosure is clearly operational and product-development focused, it does not fit the discrete event categories (no earnings release, M&A, executive change, or litigation). As a clinical-stage pharmaceutical company's announcement of material preclinical progress on its lead candidate, this is a significant operational milestone that would affect a reasonable investor's assessment of the company's development trajectory and commercial prospects.
View raw filing on EDGAR →
6-K
Material Litigation
confidence 95%
filed 2026-06-25
InMode disclosed a patent infringement lawsuit filed by Serendia LLC on June 22, 2026, alleging infringement of four U.S. patents related to the Company's Morpheus8 microneedling devices. The complaint seeks unspecified damages and an injunction against importation and sale of the accused products, and a parallel ITC complaint seeks exclusion and cease-and-desist orders. This is material litigation that would affect a reasonable investor's assessment of the Company's ability to continue selling a key product line.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-25
Item 1.01
REalloys entered into a Securities Purchase Agreement on June 24, 2026, to issue approximately 7,017,540 shares of common stock in a private placement at $14.25 per share, generating approximately $100 million in gross proceeds. The unregistered shares are being sold to accredited investors under Section 4(a)(2) and Regulation D Rule 506(b), with registration rights agreements and lock-up provisions for officers and directors.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-25
Item 1.02
The filing discloses termination of a material merger agreement between BPGC Acquisition Corp. and iRocket Technologies, Inc. dated July 22, 2025. iRocket terminated the Merger Agreement on April 14, 2026, pursuant to a contractual deadline provision (March 16, 2026), and subsequent reinstatement discussions failed. This is a material M&A event under Item 1.02 involving the termination of a definitive merger agreement that would have constituted a change of control.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-06-25
EX-99.1
EShallGo announced a registered direct offering of 454,968 Class A Ordinary Shares at $3.25 per share, raising approximately $1.479 million in gross proceeds. This is a registered equity issuance under a Form F-3 shelf registration statement, which dilutes existing shareholders. The offering is material to investors as it affects share count, ownership percentages, and the company's capital structure.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-25
Item 1.01
Z Squared Inc. entered into a binding Letter of Intent on June 18, 2026, to acquire a majority membership interest in Paradox Data LLC, a digital infrastructure company with next-generation data center development assets. The transaction involves issuance of $5 million in Series D Convertible Preferred Stock and represents a significant strategic expansion into AI infrastructure and data center development.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-25
Item 8.01
GigCapital8 has entered into a non-binding letter of intent with Quantisimo Corp. (a special purpose vehicle established by WISeKey and SEALSQ) to combine through a business combination, with an initial enterprise value of approximately $575 million and expectations to reach $2 billion through additional acquisitions. This is a material acquisition/change-of-control transaction that would result in a combined public company, requiring shareholder approval and regulatory clearance. The disclosure explicitly states the parties intend to execute definitive agreements and complete the transaction in Q1 2027.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-25
Item 5.07
This Item 5.07 disclosure reports the results of Aeva Technologies' 2026 Annual Meeting of Stockholders held on June 18, 2026, including voting outcomes for the election of Class II directors (Hrach Simonian and Stephen Zadesky) and ratification of Deloitte & Touche LLP as independent auditor. The filing presents vote tallies (FOR, AGAINST, WITHHOLD, ABSTAIN, and broker non-votes) for each proposal, which is the standard format for shareholder vote results disclosures.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 98%
filed 2026-06-25
EX-99.1
This press release discloses the results of GigaMedia's Annual General Meeting held on 25 June 2026, presenting poll results for five resolutions including adoption of audited financial statements, approval of auditors, directors' remuneration, share allotment authority, and share purchase mandate. The detailed voting tallies and percentages for each resolution are the core content, matching the shareholder_vote_results taxonomy precisely.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-06-25
The 6-K discloses the results of ORIX Corporation's 63rd Annual General Meeting of Shareholders held on June 23, 2026, including voting outcomes on three proposals: amendments to Articles of Incorporation (two proposals) and election of ten directors. The filing presents detailed voting tallies (approvals, disapprovals, abstentions, and approval rates) for each matter, which is the core content of a shareholder vote results disclosure. This is material because director elections and bylaw amendments affect governance and investor rights.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-06-25
EX-99.1
This exhibit is a press release announcing Trip.com Group's unaudited financial results for the first quarter of 2026, including total net revenues of RMB16.2 billion (up 17% YoY), net income of RMB2.5 billion, and forward guidance for Q2 2026 (3–8% YoY growth). The document contains consolidated balance sheets and statements of income, making it a discrete earnings announcement rather than a periodic financial report filing. Material to investors as it discloses quarterly operating performance and revised growth outlook.
View raw filing on EDGAR →
8-K
Operational Other
confidence 85%
filed 2026-06-25
Item 8.01
Kymera announced completion of enrollment in the Phase 2b BROADEN2 trial of KT-621 for atopic dermatitis ahead of schedule, with topline data accelerated to year-end 2026 (six months earlier than prior guidance) and Phase 3 initiation planned for mid-2027. This material clinical development milestone affects investor assessment of the company's pipeline progress and regulatory trajectory.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-06-25
Item 1.01
Grayscale Solana Staking ETF reduced its annual Sponsor's Fee from 0.35% to 0.19% of aggregate Trust assets and Sponsor's Staking Fee from 23% to 7%, effective June 25, 2026, pursuant to Amendment No. 3 to the Trust Agreement. This material reduction in the fund's fee structure directly affects investor returns and the ETF's cost economics.
View raw filing on EDGAR →